Port Wine Stains
8
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Treatment Research
18 treatments under study, led by Pulse Dye Laser
Research Leaders
10 sponsors active, led by Beckman Laser Institute University of California Irvine
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
1 terminated out of 8 trials
83.3%
-3.3% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (8)
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains
Lip Reduction Surgery for Port-wine Macrocheilia
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
The Effects of Aldara as an Adjunct to Laser Treatment
Port Wine Stains Treatment Matrix RF Study
Research Network
Common Treatments
- Pulse Dye Laser1
- Imiquimod1
- Nonmedicated Petroleum Cream1
- Combined Photodynamic Pulsed Dye Laser Treatment1
- Matrix Rf1
Active Sponsors
- Beckman Laser Institute University of California Irvine2
- University of California, Irvine2
- Graceway Pharmaceuticals, LLC1
- Second Affiliated Hospital of Xi'an Jiaotong University1
- AFT Pharmaceuticals, Ltd.1
Top Investigators
University of Kentucky
AFT Pharmaceuticals
Beckman Laser Institute University of California Irvine
Beckman Laser Institute University of California Irvine
University of Texas Southwestern Medical Center
Related Conditions
- Subjects Diagnosed With Port Wine Stains1